Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Osteoporos Int ; 31(4): 795, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31932961

ABSTRACT

The article Impact of whole dairy matrix on musculoskeletal health and aging-current knowledge and research gaps written by N.R.W. Geiker, C. Mølgaard, S. Iuliano, R. Rizzoli,Y. Manios, L.J.C. van Loon, J.-M. Lecerf, G. Moschonis, J.-Y. Reginster, I. Givens, A. Astrup.

2.
Osteoporos Int ; 31(4): 601-615, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31728607

ABSTRACT

Dairy products are included in dietary guidelines worldwide, as milk, yoghurt, and cheese are good sources of calcium and protein, vital nutrients for bones and muscle mass maintenance. Bone growth and mineralization occur during infancy and childhood, peak bone mass being attained after early adulthood. A low peak bone mass has consequences later in life, including increased risk of osteoporosis and fractures. Currently, more than 200 million people worldwide suffer from osteoporosis, with approximately 9 million fractures yearly. This poses a tremendous economic burden on health care. Between 5% and 10% of the elderly suffer from sarcopenia, the loss of muscle mass and strength, further increasing the risk of fractures due to falls. Evidence from interventional and observational studies support that fermented dairy products in particular exert beneficial effects on bone growth and mineralization, attenuation of bone loss, and reduce fracture risk. The effect cannot be explained by single nutrients in dairy, which suggests that a combined or matrix effect may be responsible similar to the matrix effects of foods on cardiometabolic health. Recently, several plant-based beverages and products have become available and marketed as substitutes for dairy products, even though their nutrient content differs substantially from dairy. Some of these products have been fortified, in efforts to mimic the nutritional profile of milk, but it is unknown whether the additives have the same bioavailability and beneficial effect as dairy. We conclude that the dairy matrix exerts an effect on bone and muscle health that is more than the sum of its nutrients, and we suggest that whole foods, not only single nutrients, need to be assessed in future observational and intervention studies of health outcomes. Furthermore, the importance of the matrix effect on health outcomes argues in favor of making future dietary guidelines food based.


Subject(s)
Bone and Bones , Dairy Products , Osteoporosis , Adult , Aged , Aging , Animals , Calcium, Dietary , Child , Humans , Milk , Osteoporosis/epidemiology , Osteoporosis/prevention & control
3.
Obes Rev ; 19(1): 81-97, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28849612

ABSTRACT

Decades of research have reported only weak associations between the intakes of specific foods or drinks and weight gain and obesity. Randomized controlled dietary intervention trials have only shown very modest effects of changes in nutrient intake and diet composition on body weight in obese subjects. This review summarizes the scientific evidence on the role mental stress (either in or not in association with impaired sleep) may play in poor sleep, enhanced appetite, cravings and decreased motivation for physical activity. All these factors contribute to weight gain and obesity, possibly via decreasing the efficacy of weight loss interventions. We also review evidence for the role that lifestyle and stress management may play in achieving weight loss in stress-vulnerable individuals with overweight.


Subject(s)
Feeding Behavior , Obesity, Abdominal/epidemiology , Sleep , Stress, Physiological , Weight Gain , Weight Loss , Anxiety/complications , Anxiety/epidemiology , Appetite , Body Mass Index , Diet , Exercise , Humans , Life Style , Obesity, Abdominal/therapy , Observational Studies as Topic , Prevalence , Randomized Controlled Trials as Topic
4.
Eur J Clin Nutr ; 72(1): 44-56, 2018 01.
Article in English | MEDLINE | ID: mdl-28952608

ABSTRACT

Eggs are rich in nutrients and a source of essential fatty- and amino acids, and the food item with highest cholesterol content. Since the 1970s dietary recommendations have advised limiting egg intake to 2-4 a week for the healthy population, and in those diagnosed with cardiovascular disease (CVD) and type 2 diabetes (T2D) an even more restricted consumption. The aim of the present paper was to assess the recommendation to lower the dietary intake of cholesterol and especially the intake of egg to reduce the risk of CVD and T2D. We performed three web-based literature searches on human studies (observational and interventional) published within the past 10 years during spring 2015. High-quality intervention studies have found nonsignificant effects of increasing the consumption of eggs on risk markers for CVD and T2D in healthy subjects and subjects with T2D. The risk associations found in the observational studies are more likely to be attributed to a dietary pattern often accompanying high egg intake and/or the cluster of other risk factors in people with high egg consumption. Dietary patterns, physical activity and genetics affect the predisposition of CVD and T2D more than a single food item as eggs. In conclusion, up to seven eggs per week can safely be consumed, but in patients with established CVD or T2D only with special emphasis on a healthy lifestyle.


Subject(s)
Cardiovascular Diseases/prevention & control , Diabetes Mellitus, Type 2/prevention & control , Diet, Healthy , Eggs/adverse effects , Evidence-Based Medicine , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/etiology , Cholesterol, Dietary/adverse effects , Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/etiology , Diet/adverse effects , Healthy Lifestyle , Humans , Meta-Analysis as Topic , Risk Factors , Systematic Reviews as Topic
5.
Clin Obes ; 7(2): 98-104, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28112868

ABSTRACT

Among women with hypertrophic breasts, the clear majority are overweight or obese. Owing to increased risk of complications, women with a body mass index (BMI) above 25 kg m -2 are precluded from reduction mammaplasty. The primary aim was to investigate if intensive weight loss could ready women with overweight for breast reduction surgery. Six women, all overweight [BMI 30.9 {28.5; 35.8} kg m -2 ] with symptomatic hypertrophy of the breast, were included a 12-week weight loss program. All women desired reduction mammaplasty and were motivated for preoperational weight loss. The first 8 weeks consisted of a formula-based diet supplying 800 kcal daily, in the subsequent 4 weeks regular foods were reintroduced increasing the intake to 1200 kcal daily. Five women completed the trial, and achieved a median (range) weight loss of 10.2 (6.5; 19) kg. Initial breast volume was 1100-2500 mL per breast, this was reduced by 300 (200; 500) mL after the intervention; equivalent to approximately 19%. Waist, hip, upper arm and thorax circumference were significantly reduced following weight loss. At end of study, all the women still suffered from symptomatic breast hypertrophy to substantiate reduction mammaplasty. Surgeries were performed 2 months thereafter. A 12-week intensive preoperative weight loss program enabled women with obesity for breast reduction surgery. Breast size was reduced proportionally more than total weight loss among women with hypertrophy.


Subject(s)
Breast/abnormalities , Breast/pathology , Diet, Reducing/methods , Hypertrophy/surgery , Mammaplasty , Overweight/diet therapy , Weight Loss , Adult , Breast/surgery , Female , Humans , Hypertrophy/etiology , Middle Aged , Organ Size , Overweight/complications , Pilot Projects , Preoperative Period , Treatment Outcome , Weight Reduction Programs/methods
6.
BJOG ; 123(2): 190-8, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26841002

ABSTRACT

OBJECTIVE: To develop maternal, fetal, and neonatal composite outcomes relevant to the evaluation of diet and lifestyle interventions in pregnancy by individual patient data (IPD) meta-analysis. DESIGN: Delphi survey. SETTING: The International Weight Management in Pregnancy (i-WIP) collaborative network. Sample Twenty-six researchers from the i-WIP collaborative network from 11 countries. METHODS: A two-generational Delphi survey involving members of the i-WIP collaborative network (26 members in 11 countries) was undertaken to prioritise the individual outcomes for their importance in clinical care. The final components of the composite outcomes were identified using pre-specified criteria. MAIN OUTCOME MEASURES: Composite outcomes considered to be important for the evaluation of the effect of diet and lifestyle in pregnancy. RESULTS: Of the 36 maternal outcomes, nine were prioritised and the following were included in the final composite: pre-eclampsia or pregnancy-induced hypertension, gestational diabetes mellitus (GDM), elective or emergency caesarean section, and preterm delivery. Of the 27 fetal and neonatal outcomes, nine were further evaluated, with the final composite consisting of intrauterine death, small for gestational age, large for gestational age, and admission to a neonatal intensive care unit (NICU). CONCLUSIONS: Our work has identified the components of maternal, fetal, and neonatal composite outcomes required for the assessment of diet and lifestyle interventions in pregnancy by IPD meta-analysis.


Subject(s)
Cesarean Section/statistics & numerical data , Diabetes, Gestational/epidemiology , Obesity/prevention & control , Pre-Eclampsia/epidemiology , Pregnancy Complications/prevention & control , Pregnant Women , Premature Birth/etiology , Adult , Delphi Technique , Diabetes, Gestational/etiology , Diet, Reducing , Female , Humans , Infant, Newborn , Life Style , Obesity/complications , Pre-Eclampsia/etiology , Pregnancy , Pregnancy Complications/etiology , Pregnancy Outcome , Premature Birth/epidemiology , Weight Gain
7.
Int J Obes (Lond) ; 39(5): 721-6, 2015 May.
Article in English | MEDLINE | ID: mdl-25540980

ABSTRACT

The importance of the relative dietary content of protein, carbohydrate and the type of carbohydrate (that is, glycemic index (GI)) for weight control under ad libitum conditions has been controversial owing to the lack of large scale studies with high diet adherence. The Diet, Obesity and Genes (DioGenes) European multicentre trial examined the importance of a slight increase in dietary protein content, reduction in carbohydrate and the importance of choosing low (LGI) vs high GI (HGI) carbohydrates for weight control in 932 obese families. Only the adults underwent a diet of 800 kcal per day for 8 weeks, and after losing ~11kg they were randomized to one of five energy ad libitum diets for 6 months. The diets differed in protein content and GI. The high-protein (HP) diet groups consumed 5.4% points more energy from protein than the normal protein (NP) groups, and the LGI diet groups achieved 5.1% lower GI than the HGI groups. The effect of HP and LGI was additive on weight loss and maintenance, and the combination was successful in preventing weight regain and reducing drop-out rate among the adults after the 11kg weight loss. This diet also reduced body fatness and prevalence of overweight and obesity among their children and had consistent beneficial effects on blood pressure, blood lipids and inflammation in both parents and children. After 1 year, mainly the HP effects were maintained. Putative genes have been identified that suggest this diet to be particularly effective in 67% of the population. In conclusion, the DioGenes diet has shown to be effective for prevention of weight regain and for weight reduction in overweight children under ad libitum conditions. The less-restrictive dietary approach fits into a normal food culture, and has been translated into popular diet and cook books in several languages.


Subject(s)
Diabetes Mellitus, Type 2/prevention & control , Diet, Reducing , Dietary Proteins/administration & dosage , Obesity/prevention & control , Patient Compliance/statistics & numerical data , Weight Reduction Programs/methods , Comorbidity , Diabetes Mellitus, Type 2/diet therapy , Diabetes Mellitus, Type 2/etiology , Dietary Carbohydrates/administration & dosage , Evidence-Based Practice , Genetic Predisposition to Disease , Glycemic Index , Humans , Obesity/complications , Obesity/diet therapy , Randomized Controlled Trials as Topic , Weight Loss
SELECTION OF CITATIONS
SEARCH DETAIL
...